Pfizer Omicron-Targeted Bivalent Vaccine 780,000 Doses to Be Introduced Domestically on the 13th
![[Image source=Yonhap News]](http://www.asiae.co.kr/news/img_view.htm?img=2022101311160667377_1665627367.jpg)
[Asia Economy Reporter Byun Seon-jin] The COVID-19 Vaccination Response Promotion Team announced that 780,000 doses of Pfizer's Omicron variant BA.1-targeting bivalent vaccine, 'Comirnaty 2-dose,' will be introduced into the country through Incheon Airport on the 13th.
This vaccine is an mRNA-based vaccine expressing antigens of the original COVID-19 virus and BA.1 variant respectively. It was developed for use as an additional dose following the primary vaccination series in individuals aged 12 and older.
The utilization plan for Pfizer's bivalent vaccine will be established after expert consultation and review by the Vaccination Expert Committee. Pfizer's bivalent vaccine received approval from the Ministry of Food and Drug Safety on the 7th.
Hot Picks Today
!["It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- Dramatic Agreement Reached on Eve of Samsung Electronics General Strike... Minister Kim Young-hoon: "Showcased Korea's Strength in Dialogue" (Update)
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The government plans to continue discussions with pharmaceutical companies to ensure stable vaccine supply and will promptly provide information on additional supply schedules as they are determined.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
